US 10508103
Benzimidazole-linked indole compound acting as novel divalent IAP antagonist
granted A61KA61K31/4184A61P
Quick answer
US patent 10508103 (Benzimidazole-linked indole compound acting as novel divalent IAP antagonist) held by Medshine Discovery Inc. expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/4184, A61P, A61P31/20, A61P35/00